Pigeum

Prunus africana (Hook. f.) Kalkm.

Bibliografia

  • Barlet A, Albrecht J, Aubert A, Fischer M, Grof F, Grothuesmann HG, Masson JC, Mazeman E, Mermon R, Reichelt H, et al. (1990) [Efficacy of Pygeum africanum extract in the medical therapy of urination disorders due to benign prostatic hyperplasia: evaluation of objective and subjective parameters. A placebo-controlled double-blind multicenter study]. Wien Klin Wochenschr. 23;102(22):667-73.
  • Bassi P, Artibani W, De Luca V, Zattoni F, Lembo A. (1987) [Standardized extract of Pygeum africanum in the treatment of benign prostatic hypertrophy. Controlled clinical study versus placebo]. Minerva Urol Nefrol. ;39(1):45-50.
  • Bauer HW (1986) Prostaglandin E2 in prostatitis and hyperplasia of the prostate.
  • Urol Int 41:139
  • Bombardelli E (1985) Methods composition and compounds for the treatment of prostatic adenoma. European Patent Application N8330491.3
  • Breza J, Dzurny O, Borowka A, Hanus T, Petrik R, Blane G, Chadha-Boreham H. (1998) Efficacy and acceptability of tadenan (Pygeum africanum extract) in the treatment of benign prostatic hyperplasia (BPH): a multicentre trial in central Europe. Curr Med Res Opin. ;14(3):127-39.
  • Briley M, Carilla E, et al. (1983) Permixon, a new treatment for benign prostatic
  • hyperplasia. Brit. J Pharmacol 79:327-36
  • Carani C, Salvioli V, Scuteri A, Borelli A, Baldini A, Granata AR, Marrama P. (1991) [Urological and sexual evaluation of treatment of benign prostatic disease using Pygeum africanum at high doses]. Arch Ital Urol Nefrol Androl. ;63(3):341-5.
  • Chatelain C, Autet W, Brackman F. (1999) Comparison of once and twice daily dosage forms of Pygeum africanum extract in patients with benign prostatic hyperplasia: a randomized, double-blind study, with long-term open label extension. Urology. ;54(3):473-8.
  • Chen MW, Levin RM, Horan P, Buttyan RB. (1999) Effects of Unilateral Ischemia on the Contractile Response of the Bladder: Protective Effect of Tadenan (Pygeum africanum Extract). Mol Urol. ;3(1):5-10.
  • Choo MS, Bellamy F, Constantinou CE. (2000) Functional evaluation of Tadenan on micturition and experimental prostate growth induced with exogenous dihydrotestosterone. Urology. 55(2):292-8.
  • Clavert A, Cranz C, Riffaud JP, Marquer C, Lacolle JY, Bollack C. (1986) [Effects of an extract of the bark of Pygeum africanum (V.1326) on prostatic secretions in the rat and in man]. Ann Urol (Paris). ;20(5):341-3.
  • Dagues F, Costa P. (1995) [Medical treatment of disorders of the bladder sphincter]. Rev Prat. 1;45(3):337-41.
  • Dufour B, Choquenet C, Revol M, Faure G, Jorest R. (1984) [Controlled study of the effects of Pygeum africanum extract on the functional symptoms of prostatic adenoma]. Ann Urol (Paris). ;18(3):193-5.
  • Gomes CM, Disanto ME, Horan P, Levin RM, Wein AJ, Chacko S. (2000) Improved contractility of obstructed bladders after tadenan treatment is associated with reversal of altered myosin isoform expression. J Urol. ;163(6):2008-13.
  • Hartmann RW, Mark M, et al. Inhibition of 5a-reductase and aromatase by
  • PHL-00801 (Prostatonin), a combination of PY102 (Pygeum africanum) and UR
  • 102 (Urtica dioica) extracts. Phytomed III(2): 121-8 1996
  • Kozay M. (1987) Inhibition of glucosyl-transferase from Streptococcus mutans by
  • oleanolic acid and ursolic acid. Caries Research 21:104-7
  • Krzeski T, Kazon M, Borkowski A, Witeska A, Kuczera J. (1993) Combined extracts of Urtica dioica and Pygeum africanum in the treatment of benign prostatic hyperplasia: double-blind comparison of two doses. Clin Ther. ;15(6):1011-20.
  • Levin RM, Levin SS, Zhao Y, Buttyan R. (1997) Cellular and molecular aspects of bladder hypertrophy. Eur Urol. ;32 Suppl 1:15-21.
  • Mathe G, Hallard M, Bourut CH, Chenu E. (1995) Pygeum africanum extract with so-called phyto-estrogenic action markedly reduces the volume of true and large prostatic hypertrophy. Biomed Pharmacother. ;49(7-8):341-3.
  • Mathe G, Orbach-Arbouys S, Bizi E, Court B. (1995) The so-called phyto-estrogenic action of Pygeum africanum extract. Biomed Pharmacother. ;49(7-8):339-40
  • Menchini-Fabris GF, Giorgi P, Andreini F, Canale D, Paoli R, Sarteschi ML. (1988) [New perspectives on the use of Pygeum Africanum in prostato-bladder pathology]. Arch Ital Urol Nefrol Androl. ;60(3):313-22
  • Paubert-Braquet M, Cave A, Hocquemiller R, Delacroix D, Dupont C, Hedef N, Borgeat P. (1994) Effect of Pygeum africanum extract on A23187-stimulated production of lipoxygenase metabolites from human polymorphonuclear cells. J Lipid Mediat Cell Signal. ;9(3):285-90.
  • Stevens, P.F. (2001 onwards). Angiosperm Phylogeny Website. Version 5, May 2004 [and more or less continuously updated since]. http://www.mobot.org/MOBOT/research/APweb/
  • Thieblot L, Berthelay S, Berthelay J. (1971) [Preventive and curative action of a bark extract from an African plant, Pygeum africanum, on experimental prostatic adenoma in rats]. Therapie. ;26(3):575-80.
  • Thieblot L, Grizard G, Boucher D. (1977) [Effect of V 1326 (active principle of Pygeum africanum bark extract) on hypophyseo-genito-adrenal axis in rats]. Therapie. ;32(1):99110.
  • Yablonsky F, Nicolas V, Riffaud JP, Bellamy F. (1997) Antiproliferative effect of Pygeum africanum extract on rat prostatic fibroblasts. J Urol. Jun;157(6):2381-7.

Glossario